The safety and efficacy of intravenous immunoglobulin in autoimmune encephalitis

OBJECTIVE: Although intravenous immunoglobulin (IVIG) is the first‐line immunotherapy in autoimmune encephalitis, all supporting evidence comes from retrospective case series. Here, we performed a prospective clinical trial of IVIG for functional recovery in autoimmune encephalitis. METHODS: This si...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Soon‐Tae, Lee, Han Sang, Lee, Woo‐Jin, Cha, Han‐A, Kim, Seon Hui, Shin, Seo‐Yi, Chu, Kon, Lee, Sang Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082384/
https://www.ncbi.nlm.nih.gov/pubmed/35315247
http://dx.doi.org/10.1002/acn3.51540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9082384/
https://www.ncbi.nlm.nih.gov/pubmed/35315247
http://dx.doi.org/10.1002/acn3.51540

Ejemplares similares